Tubastatin A

Modify Date: 2024-01-03 01:23:57

Tubastatin A Structure
Tubastatin A structure
Common Name Tubastatin A
CAS Number 1239262-52-2 Molecular Weight 449.42
Density 1.3±0.1 g/cm3 Boiling Point N/A
Molecular Formula C22H22F3N3O4 Melting Point N/A
MSDS Chinese USA Flash Point N/A

 Use of Tubastatin A


Tubastatin A (TSA) TFA is a potent and selective?HDAC6?inhibitor with?IC50?of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more). Tubastatin A TFA also inhibits HDAC10 and metallo-β-lactamase domain-containing protein?2 (MBLAC2).

 Names

Name Tubastatin A Trifluoroacetate
Synonym More Synonyms

 Tubastatin A Biological Activity

Description Tubastatin A (TSA) TFA is a potent and selective?HDAC6?inhibitor with?IC50?of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more). Tubastatin A TFA also inhibits HDAC10 and metallo-β-lactamase domain-containing protein?2 (MBLAC2).
Related Catalog
Target

IC50: 15 nM (HDAC6)[1]

In Vitro Tubastatin A is substantially selective for all 11 HDAC isoforms and maintains over 1000-fold selectivity against all isoforms excluding HDAC8, where it has approximately 57-fold selectivity. In homocysteic acid (HCA) induced neurodegeneration assays, Tubastatin A displays dose-dependent protection against HCA-induced neuronal cell death starting at 5 μM with near complete protection at 10 μM[1].?At 100 ng/mL Tubastatin A increases Foxp3+ T-regulatory cells (Tregs) suppression of T cell proliferation in vitro[2].?Tubastatin A treatment in CC12 cells would lead to myotube formation impairment when alpha-tubulin is hyperacetylated early in the myogenic process; however, myotube elongation occurs when alpha-tubulin is hyeperacetylated in myotubes[3].?A recent study indicates that Tubastatin A treatment increases cell elasticity as revealed by atomic force microscopy (AFM) tests without exerting drastic changes to the actin microfilament or microtubule networks in mouse ovarian cancer cell lines, MOSE-E and MOSE-L[4].
In Vivo Daily treatment of Tubastatin A at 0.5 mg/kg inhibits HDAC6 to promote Tregs suppressive activity in mouse models of inflammation and autoimmunity, including multiple forms of experimental colitis and fully major histocompatibility complex (MHC)-incompatible cardiac allograft rejection[2].
References

[1]. de Zoeten EF, et al. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells. Mol Cell Biol. 2011 May;31(10):2066-78.  

[2]. Kyle V. Butler et al. Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A J. Am. Chem. Soc., 2010, 132 (31), pp 10842-10846  

[3]. Di Fulvio S, et al. Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation. PLoS One. 2011;6(12):e28563  

[4]. Ketene AN, et al. Actin filaments play a primary role for structural integrity and viscoelastic response in cells. Integr Biol (Camb). 2012 May;4(5):540-9.  

[5]. Brijmohan AS, et al. HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease. Front Pharmacol. 2018 Feb 1;9:34.  

[6]. Severin Lechner, et al. Target deconvolution of HDAC pharmacopoeia reveals MBLAC2 as common off-target. Nat Chem Biol. 2022 Apr 28.  

 Chemical & Physical Properties

Density 1.3±0.1 g/cm3
Molecular Formula C22H22F3N3O4
Molecular Weight 449.42
Exact Mass 335.163391
PSA 94.80000
LogP 2.14
Index of Refraction 1.668

 Synthetic Route

~31%

Tubastatin A Structure

Tubastatin A

CAS#:1239262-52-2

Literature: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS; KOZIKOWSKI, Alan; BUTLER, Kyle, B.; KALIN, Jay, Hans Patent: WO2011/11186 A2, 2011 ; Location in patent: Page/Page column 54-55 ; WO 2011/011186 A2

~%

Tubastatin A Structure

Tubastatin A

CAS#:1239262-52-2

Literature: WO2011/11186 A2, ; WO 2011/011186 A2

~%

Tubastatin A Structure

Tubastatin A

CAS#:1239262-52-2

Literature: WO2011/11186 A2, ; WO 2011/011186 A2

~%

Tubastatin A Structure

Tubastatin A

CAS#:1239262-52-2

Literature: WO2011/11186 A2, ; WO 2011/011186 A2

~%

Tubastatin A Structure

Tubastatin A

CAS#:1239262-52-2

Literature: Journal of the American Chemical Society, , vol. 132, # 31 p. 10842 - 10846

 Synonyms

TUBASTATIN A HYDROCHLORIDE
N-hydroxy-4-({2-methyl-1H,3H,4H-pyrido[4,3-b]indol-5-yl}methyl)benzamide hydrochloride
N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)methyl]benzamide
Benzamide, N-hydroxy-4-[(1,2,3,4-tetrahydro-2-methyl-5H-pyrido[4,3-b]indol-5-yl)methyl]-
Tubastatin A Trifluoroacetic Acid Salt
TUBASTSTINA HCL
TUBASTATIN A ((2-METHYL-3,4-DIHYDRO-1H-PYRIDO[4,3-B]-INDOL- 5(2H)-YL)METHYL)BENZAMIDE)
TUBASTATIN A_HCL
Tubastatin A
TUBASTANTIN A
Tubastatin A (trifluoroacetate salt)
TRIETHYLENETHIOPHOSPHORAMIDE,WHITE SOLID
[4-({2-methyl-1H,2H,3H,4H,5H-pyrido[4,3-b]indol-5-yl}methyl)phenyl]formamido 2,2,2-trifluoroacetate
N-Hydroxy-4-[(2-methyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5 -yl)methyl]benzamide
N-hydroxy-4-((2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)methyl)benzamide